obesity drug news today glp-1 october 23 2025 Overdoses Are Rising as Telehealth Weight-Loss Prescriptions Boom Outlook for obesity in 2025:
Description
Lippincott Williams and Wilkins
8991 While DPP4 inhibitors have been extensively used in the treatment of type 2 diabetes mellitus (T2DM) for over a decade, their efficacy in T1DM remains uncertain
10.14309/01.ajg.0000594772.87672.64 32 FernandezA
Hypomagnesemia (low magnesium) may occur with prolonged diarrhea or inadequate intake
For example, GLP-1 agents can reduce postprandial glucose spikes and promote weight loss
